FI87530B - Foerfarande foer framstaellning av streptococcus equi -stammen - Google Patents
Foerfarande foer framstaellning av streptococcus equi -stammen Download PDFInfo
- Publication number
- FI87530B FI87530B FI871060A FI871060A FI87530B FI 87530 B FI87530 B FI 87530B FI 871060 A FI871060 A FI 871060A FI 871060 A FI871060 A FI 871060A FI 87530 B FI87530 B FI 87530B
- Authority
- FI
- Finland
- Prior art keywords
- equi
- strain
- avirulent
- virulent
- infection
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
- A61K39/092—Streptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S424/00—Drug, bio-affecting and body treating compositions
- Y10S424/829—Bacterial vaccine for equine species, e.g. horses
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/822—Microorganisms using bacteria or actinomycetales
- Y10S435/885—Streptococcus
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Claims (4)
1. Förfarande för framställning av en sädan stam av Streptococcus equi som är avirulent för hästar, kannetecknat av att det omfattar följande steg: 1. man utsätter en virulent stam av S. equi CF32 (ATCC 53185) för mutationsbildning vid behandling med kemisk mutagen eller strälning, och 2. den resulterande avirulenta och skyddande stammen se-lekteras vid undersökning av icke-inkapslade kolonier och med selektering av stammen, som är avirulent, innehäller M-proteinfragment, vars molekylvikt är 41 000 och som medför S. equi -antikroppsförsvar.
2. Förfarande enligt patentkravet 1, kännetecknat av att den virulenta stammen av Streptococcus equi muteras vid kemisk induserad mutagenes eller vid strälninginduserat muta-genes.
3. Förfarande enligt patentkravet 2, kännetecknat av att den virulenta stammen av S. equi muteras vid behandling av nitrosoguanin och den avirulenta och skyddande stammen väljs ut vid undersökning av icke-inkapslade kolonier och selektering av en stam, som är avirulent pä möss efter intraperi-toneal inokulering, skyddar möss mot den virulenta stammen och som innehäller M-proteinfragment, vars molekylvikt är cirka 41 000 och som medför S. equi -antikroppsreaktion.
4. Förfarande enligt patentkravet 3, kännetecknat av att den avirulenta stammen av S. equi är Streptococcus equi 709-27, som deponerats tili ATCC med nummer 53186.
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US75461385A | 1985-07-12 | 1985-07-12 | |
| US75461385 | 1985-07-12 | ||
| US8601460 | 1986-07-14 | ||
| PCT/US1986/001460 WO1987000436A1 (en) | 1985-07-12 | 1986-07-14 | The protection of equines against streptococcus equi |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| FI871060A0 FI871060A0 (fi) | 1987-03-11 |
| FI871060A FI871060A (fi) | 1987-03-11 |
| FI87530B true FI87530B (fi) | 1992-10-15 |
| FI87530C FI87530C (sv) | 1993-01-25 |
Family
ID=25035573
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI871060A FI87530C (sv) | 1985-07-12 | 1987-03-11 | Förfarande för framställning av Streptococcus equi -stammen |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US5183659A (sv) |
| EP (1) | EP0230456B1 (sv) |
| JP (1) | JPH0816064B2 (sv) |
| AR (1) | AR241545A1 (sv) |
| AT (1) | ATE71532T1 (sv) |
| AU (1) | AU604645B2 (sv) |
| CA (1) | CA1281287C (sv) |
| DE (1) | DE3683478D1 (sv) |
| DK (1) | DK167599B1 (sv) |
| ES (1) | ES2000491A6 (sv) |
| FI (1) | FI87530C (sv) |
| GR (1) | GR861795B (sv) |
| IE (1) | IE58964B1 (sv) |
| NO (1) | NO169997C (sv) |
| NZ (1) | NZ216796A (sv) |
| PT (1) | PT82971B (sv) |
| WO (1) | WO1987000436A1 (sv) |
| ZA (1) | ZA865156B (sv) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2523883Y2 (ja) * | 1992-02-24 | 1997-01-29 | 株式会社三協精機製作所 | プーリ付調速器 |
| ZA97452B (en) | 1996-01-25 | 1997-08-15 | Trinity College Dublin | Streptococcus equi vaccine. |
| US6086894A (en) * | 1996-06-27 | 2000-07-11 | Virginia Tech Intellectual Properties, Inc. | Recombinant vaccine for diseases caused by encapsulated organisms |
| EP0993469A1 (en) | 1997-06-24 | 2000-04-19 | John F. Timoney | COMPOUNDS ENCODING THE PROTECTIVE M-LIKE PROTEIN OF $i(STREPTOCOCCUS EQUI) AND ASSAYS THEREFOR |
| CA2243730C (en) * | 1997-07-29 | 2009-12-22 | Akzo Nobel N.V. | Streptococcus equi vaccine |
| US20070059327A2 (en) * | 1998-01-15 | 2007-03-15 | Wyeth | Streptococcus equi compositions and methods of use |
| DE60007668T2 (de) * | 1999-01-26 | 2004-12-02 | Akzo Nobel N.V. | Verwendung lebender abgeschwächter Bakterien zur Herstellung eines submukosalen Impstoffes |
| CA2501621C (en) | 2002-10-11 | 2012-01-24 | Bengt Guss | Immunization of non-human mammals against streptococcus equi |
| US20110020403A1 (en) | 2007-12-13 | 2011-01-27 | Bengt Guss | immunizing composition |
| EP2590994B1 (en) | 2010-05-26 | 2016-11-02 | Intervacc AB | Vaccine against streptococcal infections based on recombinant proteins |
| EP3057613A1 (en) | 2013-10-17 | 2016-08-24 | Zoetis Services LLC | Methods and compositions for treatment of s. equi infection |
| KR101694676B1 (ko) * | 2015-12-10 | 2017-01-10 | 우진 비앤지 주식회사 | 말 선역 질병원인 국내 분리 스트렙토코커스 이콰이 균주 및 이를 포함하는 백신 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3793150A (en) * | 1971-01-20 | 1974-02-19 | Richardson Merrell Inc | Equine strangles vaccine and method of preparing and using the same |
| US3852420A (en) * | 1971-01-20 | 1974-12-03 | Richardson Merrell Inc | Equine strangles vaccine and method of preparing and using the same |
| IL52815A (en) * | 1977-08-24 | 1983-03-31 | Israel State | Fowl cholera vaccine and process for producing an attenuated non-virulent strain of pasteurella multocida |
| JPS60251898A (ja) * | 1984-05-25 | 1985-12-12 | Shiseido Co Ltd | 醗酵法によるヒアルロン酸の製造方法 |
| US4582798A (en) * | 1984-11-23 | 1986-04-15 | Miles Laboratories, Inc. | Preparation and use of enzyme-detergent extracted Streptococcus equi vaccine |
-
1985
- 1985-07-11 AR AR85304497A patent/AR241545A1/es active
-
1986
- 1986-07-09 NZ NZ216796A patent/NZ216796A/xx unknown
- 1986-07-09 GR GR861795A patent/GR861795B/el unknown
- 1986-07-10 ZA ZA865156A patent/ZA865156B/xx unknown
- 1986-07-10 IE IE185286A patent/IE58964B1/en not_active IP Right Cessation
- 1986-07-10 ES ES8600234A patent/ES2000491A6/es not_active Expired
- 1986-07-10 CA CA000513457A patent/CA1281287C/en not_active Expired - Lifetime
- 1986-07-11 PT PT82971A patent/PT82971B/pt not_active IP Right Cessation
- 1986-07-14 AU AU61496/86A patent/AU604645B2/en not_active Expired
- 1986-07-14 AT AT86904663T patent/ATE71532T1/de not_active IP Right Cessation
- 1986-07-14 DE DE8686904663T patent/DE3683478D1/de not_active Expired - Lifetime
- 1986-07-14 WO PCT/US1986/001460 patent/WO1987000436A1/en active IP Right Grant
- 1986-07-14 JP JP61504034A patent/JPH0816064B2/ja not_active Expired - Lifetime
- 1986-07-14 EP EP86904663A patent/EP0230456B1/en not_active Expired - Lifetime
-
1987
- 1987-03-11 DK DK125887A patent/DK167599B1/da not_active IP Right Cessation
- 1987-03-11 NO NO871012A patent/NO169997C/no not_active IP Right Cessation
- 1987-03-11 FI FI871060A patent/FI87530C/sv not_active IP Right Cessation
-
1988
- 1988-06-15 US US07/207,320 patent/US5183659A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| FI871060A0 (fi) | 1987-03-11 |
| FI87530C (sv) | 1993-01-25 |
| WO1987000436A1 (en) | 1987-01-29 |
| ES2000491A6 (es) | 1988-03-01 |
| AR241545A1 (es) | 1992-08-31 |
| FI871060A (fi) | 1987-03-11 |
| ZA865156B (en) | 1987-05-27 |
| AU6149686A (en) | 1987-02-10 |
| IE861852L (en) | 1987-01-11 |
| CA1281287C (en) | 1991-03-12 |
| NO871012L (no) | 1987-03-11 |
| NO169997C (no) | 1992-09-02 |
| PT82971A (pt) | 1986-08-01 |
| JPS63500596A (ja) | 1988-03-03 |
| DK167599B1 (da) | 1993-11-29 |
| AU604645B2 (en) | 1991-01-03 |
| NZ216796A (en) | 1991-11-26 |
| DK125887D0 (da) | 1987-03-11 |
| GR861795B (en) | 1986-11-11 |
| NO169997B (no) | 1992-05-25 |
| DK125887A (da) | 1987-03-11 |
| PT82971B (pt) | 1988-07-01 |
| ATE71532T1 (de) | 1992-02-15 |
| IE58964B1 (en) | 1993-12-01 |
| EP0230456A4 (en) | 1987-10-27 |
| DE3683478D1 (de) | 1992-02-27 |
| JPH0816064B2 (ja) | 1996-02-21 |
| EP0230456B1 (en) | 1992-01-15 |
| EP0230456A1 (en) | 1987-08-05 |
| NO871012D0 (no) | 1987-03-11 |
| US5183659A (en) | 1993-02-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Ruffolo et al. | Cloning, sequencing, expression, and protective capacity of the oma87 gene encoding the Pasteurella multocida 87-kilodalton outer membrane antigen | |
| Gilmour et al. | Vaccine containing iron-regulated proteins of Pasteurella haemolytica A2 enhances protection against experimental pasteurellosis in lambs | |
| FI87530B (fi) | Foerfarande foer framstaellning av streptococcus equi -stammen | |
| JPH09215492A (ja) | ストレプトコックス エキワクチン | |
| Galán et al. | Cloning and expression in Escherichia coli of a protective antigen of Erysipelothrix rhusiopathiae | |
| Stefanelli et al. | Molecular characterization of two Bordetella bronchiseptica strains isolated from children with coughs | |
| Bouzoubaa et al. | Use of membrane proteins from Salmonella gallinarum for prevention of fowl typhoid infection in chickens | |
| Ruffolo et al. | Iron-regulated outer membrane proteins of Pasteurella multocida and their role in immunity | |
| Chandrasekaran et al. | Characterization of immune response and duration of protection in buffaloes immunized with haemorrhagic septicaemia vaccines | |
| Bronze et al. | Protective immunity evoked by locally administered group A streptococcal vaccines in mice. | |
| NO175735B (no) | Fremgangsmåte ved fremstilling av Pasteurella-vaksine | |
| Groschup et al. | Characterization of a protective protein antigen of Erysipelothrix rhusiopathiae | |
| US11633466B2 (en) | Enteric fever vaccine based on outer membrane vesicles from two different strains of typhoidal Salmonelle species | |
| Yamaguchi et al. | Isolation and characterization of a Haemophilus paragallinarum mutant that lacks a hemagglutinating antigen | |
| Frandsen et al. | Characterization of toxin from different strains of Pasteurella multocida serotype A and D | |
| Mosier et al. | Passive protection of calves with Pasteurella haemolytica antiserum | |
| Sutherland et al. | An experimental anti-idiotype vaccine mimicking lipopolysaccharide gives protection against Pasteurella multocida type A infection in mice | |
| Xu et al. | Correlation of antibody titres induced by vaccination with protection in mouse typhoid | |
| CA2071955C (en) | Reduced-protein subunit vaccine for swine dysentery | |
| Elsheikh et al. | Induction of protective immune response by vaccination against Pseudomonas pneumonia of mink | |
| McKinney et al. | Pasteurella haemolytica: purification of saline-extractable proteins by isoelectrofocusing | |
| Kumar et al. | Immunogenicity and protective role of an IgA reactive 31-kDa antigen of Vibrio cholerae O139 | |
| Petersen et al. | Proliferative responses to purified and fractionated Bordetella pertussis antigens in mice immunized with whole-cell pertussis vaccine | |
| PLANT et al. | The protein‐lipopolysaccharide complex extracted with trichloracetic acid from Salmonella typhimurium effective in protection of mice against S. typhimurium infection | |
| Adu et al. | Susceptibility of chickens vaccinated with three live Newcastle disease vaccines to challenge by Nigerian velogenic strains |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Patent granted |
Owner name: CORNELL RESEARCH FOUNDATION INC. |
|
| MA | Patent expired |